HomeCompound-BibliothekenCambridge Cancer Compound Library

Cambridge Cancer Compound Library

Kat.-Nr.L2300

Eine einzigartige Sammlung von 242 Anti-Krebs-Verbindungen für das Hochdurchsatz-Screening (HTS) und das High-Content-Screening (HCS).

96 well plates

Passen Sie Ihre Bibliothek an:

Zitiert von 334 Publikationen

Cambridge Cancer Compound Library Inhalt

Beschreibung & Vorteile

• A highly value-added library derived through a collaboration with researchers at the MIT Koch Institute
• A unique collection of cancer-targeted compounds for high throughput screening (HTS) and high content screening (HCS)
• Embraces the whole spectrum of cancer targets, from kinases to notch signaling, to metabolic targets
• Structurally diverse, medicinally active and cell permeable
• Rich documentation with structure
• NMR and HPLC to ensure the high purity

Produktdetails

Formulierung 242 compounds pre-dissolved in 10mM DMSO
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

Cambridge Cancer Compound Library Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania